Iridium‐Catalyzed Direct Reductive Amination of Ketones and Secondary Amines: Breaking the Aliphatic Wall.
- Published in:
- Chemistry - A European Journal, 2022, v. 28, n. 36, p. 1, doi. 10.1002/chem.202201078
- By:
- Publication type:
- Article
Works matching DE "JANSSEN Pharmaceutica NV"
Results: 30
1
2
Bilanz Sanofi 2023: Für Haut und Lungen.
- Published in:
- Nachrichten aus der Chemie, 2024, v. 72, n. 4, p. 43, doi. 10.1002/nadc.20244140768
- By:
- Publication type:
- Article
3
Use of Chlorfenapyr as a Termiticide for Wood Preservation.
- Published in:
- Forest Products Journal, 2003, v. 53, n. 4, p. 6
- Publication type:
- Article
4
Mentoring Driving Diversity.
- Published in:
- Organization Development Journal, 2007, v. 25, n. 2, p. P107
- By:
- Publication type:
- Article
5
News and Notices.
- Published in:
- Clinical & Experimental Dermatology, 1987, v. 12, n. 1, p. 75, doi. 10.1111/j.1365-2230.1987.tb01867.x
- Publication type:
- Article
6
Eluxadoline: First Global Approval.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
7
Dependenţa de fentanyl.
- Published in:
- Paliatia: Journal of Palliative Care, 2022, v. 15, n. 1, p. 16
- By:
- Publication type:
- Article
8
New warnings added to cisapride labeling.
- Published in:
- JAMA: Journal of the American Medical Association, 1998, v. 280, n. 5, p. 410, doi. 10.1001/jama.280.5.410-JFD80007-2-1
- Publication type:
- Article
9
Risperidone: prescribing information update.
- Published in:
- WHO Drug Information, 2003, v. 17, n. 2, p. 103
- Publication type:
- Article
10
Urgent Product Recall.
- Published in:
- Oncology Nursing Forum, 2004, v. 31, n. 2, p. 346
- Publication type:
- Article
11
Medidata Enters The Majors.
- Published in:
- Bio-IT World, 2005, v. 4, n. 5, p. 58
- By:
- Publication type:
- Article
12
Patent watch: Stelara safe after IL-12 antibody dispute.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 9, p. 647, doi. 10.1038/nrd4423
- By:
- Publication type:
- Article
13
Eli Lilly wins Alzheimer's antibody patent dispute.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 9, p. 656, doi. 10.1038/nrd4122
- Publication type:
- Article
14
Patent watch.
- Published in:
- Nature Reviews Drug Discovery, 2011, v. 10, n. 8, p. 568, doi. 10.1038/nrd3529
- Publication type:
- Article
15
From the FDA.
- Published in:
- Brown University Psychopharmacology Update, 2005, v. 16, n. 11, p. 8
- Publication type:
- Article
16
Janssen launches online resource for injectable risperidone.
- Published in:
- Brown University Psychopharmacology Update, 2004, v. 15, n. 5, p. 7
- Publication type:
- Article
17
Fast-dissolving formulations released: risperidone, clonazepam.
- Published in:
- Brown University Psychopharmacology Update, 2003, v. 14, n. 6, p. 7
- Publication type:
- Article
18
NDAs for two new formulations of risperidone.
- Published in:
- Brown University Psychopharmacology Update, 2002, v. 13, n. 2, p. 8
- Publication type:
- Article
19
NME, biologic approvals.
- Published in:
- Formulary, 2000, v. 35, n. 2, p. 106
- Publication type:
- Article
20
The importance of the laboratory to the pharmaceutical business.
- Published in:
- Journal of Automated Methods & Management in Chemistry, 2000, v. 22, n. 2, p. 47, doi. 10.1080/146392400300530
- By:
- Publication type:
- Article
21
A Risk-Based Allocation of Internal Audit Time: A Case Study.
- Published in:
- Auditing: A Journal of Practice & Theory, 1991, v. 10, n. 2, p. 49
- By:
- Publication type:
- Article
22
Paperless Progress.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 10, p. 66
- Publication type:
- Article
23
Industry chases pan-genotypic and shorter HCV treatments.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 6, p. 575, doi. 10.1038/nbt0615-575
- By:
- Publication type:
- Article
24
Plants around the world.
- Published in:
- Chemistry & Industry, 2003, n. 8, p. 16
- By:
- Publication type:
- Article
25
Successful pharmaceutical discovery: Paul Janssen's concept of drug research.
- Published in:
- R&D Management, 2007, v. 37, n. 4, p. 355, doi. 10.1111/j.1467-9310.2007.00481.x
- By:
- Publication type:
- Article
26
JANSSEN PHARMACEUTICA TO SELL ANIMAL HEALTH ACTIVITIES.
- Published in:
- Veterinary Ireland Journal, 2011, v. 64, n. 4, p. 192
- Publication type:
- Article
27
From theFDA.
- Published in:
- Brown University Child & Adolescent Psychopharmacology Update, 2005, v. 7, n. 10, p. 8
- Publication type:
- Article
28
Corporate Sponsors of the XlVth International Congress of Nephrology.
- Published in:
- 1997
- Publication type:
- Proceeding
29
Modelling the impact of JNJ-1802, a first-in-class dengue inhibitor blocking the NS3-NS4B interaction, on in-vitro DENV-2 dynamics.
- Published in:
- PLoS Computational Biology, 2023, v. 19, n. 12, p. 1, doi. 10.1371/journal.pcbi.1011662
- By:
- Publication type:
- Article
30
ethical products.
- Published in:
- 2011
- Publication type:
- Product Review